Antipsychotic Drugs Market Research Report: Information By Generation (First Generation, Second Generation), By Type (Atypical Antipsychotic, Miscellaneous Antipsychotics Agents), By Application (Schizophrenia, Anxiety, Bipolar Disorder), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030
The antipsychotic drug market refers to the pharmaceutical market that produces and sells medications used to treat psychotic disorders such as schizophrenia, bipolar disorder, and other mental illnesses. Antipsychotic drugs are also known as neuroleptics, and they work by altering the balance of certain chemicals in the brain that affect mood, behavior, and perception.
The antipsychotic drugs market size was valued at USD 21.5 billion in 2022 and is projected to grow from USD 22.7 Billion in 2023 to USD 33.5 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.70% during the forecast period (2023 – 2030).North America held the largest market share in 2020 due to the high prevalence of mental disorders in the region, followed by Europe and the Asia Pacific.
Key Players
Some of the leading companies in the antipsychotic drug market include AstraZeneca, Johnson & Johnson, Eli Lilly and Company, Bristol-Myers Squibb Company, and Pfizer, Inc. These companies invest heavily in research and development to develop new and improved drugs, as well as to expand their market presence globally.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/2784
Market Segmentation
The antipsychotic drug market can be segmented based on various factors such as drug class, distribution channel, and geography. Here are some of the common segmentation categories used in the antipsychotic drug market:
Drug class: Antipsychotic drugs can be classified into two major categories, namely first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs). FGAs, also known as typical antipsychotics, were the first generation of antipsychotic drugs developed in the 1950s. SGAs, also known as atypical antipsychotics, were developed in the 1990s and are considered to be more effective and have fewer side effects than FGAs.
Distribution channel: Antipsychotic drugs are distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies are the largest distribution channel for antipsychotic drugs as they are mostly administered in hospital settings.
Geography: The antipsychotic drug market can also be segmented based on geography, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Indication: Antipsychotic drugs are used to treat various mental health disorders, including schizophrenia, bipolar disorder, and depression. Hence, the market can also be segmented based on the indication for which the drug is prescribed.
Formulation: Antipsychotic drugs can be available in different formulations such as tablets, capsules, injectables, and liquids. This segmentation is also used to identify which formulation is most popular among patients.
End-user: Antipsychotic drugs can be prescribed to individuals of different age groups, including children, adolescents, and adults. Hence, the market can also be segmented based on the end-user group.
These segmentation categories are used by companies and analysts to understand the antipsychotic drug market and to identify opportunities for growth and expansion.
Browse In-depth Market Research Report (90 Pages) on Antipsychotic Drugs: https://www.marketresearchfuture.com/reports/antipsychotic-drugs-market-2784
Regional Analysis
The antipsychotic drug market is a global market that spans across several regions worldwide. Here is a brief regional analysis of the antipsychotic drug market:
North America: North America is the largest market for antipsychotic drugs, with the United States being the dominant country in the region. The high prevalence of mental disorders, the availability of advanced healthcare infrastructure, and favorable government initiatives are some of the key factors driving the growth of the market in North America.
Europe: Europe is the second-largest market for antipsychotic drugs, with countries such as the United Kingdom, Germany, and France being the major contributors. The increasing incidence of mental disorders and the availability of advanced healthcare facilities are the key drivers of the market growth in Europe.
Asia Pacific: The Asia Pacific region is expected to experience significant growth in the antipsychotic drug market due to the increasing prevalence of mental disorders, a rise in the aging population, and a growing demand for advanced healthcare facilities. China, Japan, and India are the major contributors to the growth of the market in this region.
Latin America: The Latin American market for antipsychotic drugs is expected to experience moderate growth due to the increasing prevalence of mental disorders, an expanding geriatric population, and the availability of advanced healthcare facilities in countries such as Brazil and Mexico.
Middle East and Africa: The Middle East and Africa market for antipsychotic drugs is expected to experience slow growth due to the lack of awareness about mental health disorders, limited healthcare facilities, and a shortage of trained healthcare professionals.
Overall, the antipsychotic drug market is expected to experience steady growth globally, with the North American and European regions being the major contributors to the growth of the market.
Discover More Research Reports on Healthcare Industry by Market Research Future:
Biopharmaceutical Excipients Market Size, Trends and Growth Outlook By Product {Solubilizers & Surfactants/Emulsifiers (Triglycerides, Esters), Polyols (Mannitol, Sorbitol), Carbohydrates (Sucrose, Dextrose, Starch), Specialty Excipients}, Formulation (Oral, Topical, Injectables) and Region (North America, Europe, Asia-Pacific, Rest of the World)—Forecast to 2030
Dental Industry Market Information By Discipline (Endodontics, Restorative Dentistry, Prosthodontics, Periodontics, Orthodontics, Cosmetic Dentistry, and Oral Surgery), By Consumables (Resin Composites, Dental Biomaterial, Dental Aesthetic, Endodontic Supplies, Gingival Retraction Material, and Whitening Material), By End-User (Hospitals & Clinics Specialty Dental Centers, and Dental Academic & Research Institutes), and Region (North America, Europe, Asia-Pacific, and the Rest of the World)—Forecast till 2030
Anxiety Disorder Treatment Market Research Report: By Drug Class (SSRIs, SNRIs, TCAs, Pregabalin, Buspirone, Benzodiazepines, Moclobemide, Others) and By End-User (Hospitals, Mental Healthcare Centers, Asylums, Others) – Forecast to 2030
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com